IXICO PLC (LSE:IXI) - Share price - Overview

Stock Report

IXICO PLC IXI

Last Price
GBX31.00

Day Change
1.00|3.33%

As of 28/04/2017
10:34:53 BST | GBX
Minimum 15 Minutes Delay.

Last Close30.00p
Day Range30.07 - 31.00
Mkt Cap8.14Mil
52-Wk Range22.00 - 44.00
Yield %0.00
ISINGB00BCLY7L40
Volume1,426
P/E-5.11
P/S2.43
P/CF-4.92

Share Price

Total Returns 27/04/2017

 Chg (%)  
More ...
IXICO PLC15.38 
FTSE 100 TR GBP-0.41
 
Financials
201420152016
More ...
Income Statement
Turnover2.563.123.11
Operating Profit-1.89-1.39-2.87
Net Profit-1.72-1.19-2.12
Reported EPS-11.39-7.90-8.70
Balance Sheet
Current Assets4.773.825.04
Non Current Assets0.640.420.65
Total Assets5.414.245.68
Current Liabilities1.501.471.49
Total Liabilities1.601.531.60
Total Equity3.812.714.09
Cash Flow
Operating Cash Flow-2.15-1.63-1.97
Net Change in Cash1.83-1.361.25
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
--------
--------
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
26/09/2016Exercise of OptionProf Derek Hill1.0029,773298.00

Company Profile

IXICO PLC is a medical technology and diagnostics company. It provides clinical trials services to the pharmaceutical industry.The Company is engaged in developing technologies in researching and treating serious diseases.

Sector

Biotechnology

Market Position

1567 of 1850 Companies

Index

FTSE AIM All Share

Outlook

(06/01/2017) no outlook statement

Next Event 07/06/2017

Next interim announcement
Ratios
CompSecMkt
More ...
PER (E)0.0014.0416.18
Div Yld (E)0.003.844.14
PEG (E)0.000.341.14
ROCE-61.22180.19-75.20
Op Mrgn-71.62-6.91-101.32
EPS Grwth0.0068.0328.17
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. Charles Spicer
Chief Financial OfficerMs. Susan Lowther
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.